About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 195 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 195 trials

CompletedStudy to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to PaliperidoneThe purpose of this study is to evaluate medication satisfaction after at least 4 weeks of paliperidone ER (extended-release), an antipsychotic, treatment in patients with…NCT00535132·Cerritos, California and 39 others RecruitingStudy to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With SchizophreniaThe purpose of this study is to assess the efficacy, safety, and tolerability of GXV813 in the treatment of an acute episode of schizophreniaNCT07467993·Bentonville, Arkansas and 15 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPharmacodynamic/Pharmacokinetic Study of AQW051 in SchizophreniaPart 1 of the study will assess the enhancement of task-related brain activation (BOLD response) in key brain areas in schizophrenia during the performance of working memory…NCT00825539·Los Angeles, California and 6 others

CompletedStudy to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderThis is a randomized, single-dose, open-label, parallel-group study.NCT05321602·Little Rock, Arkansas and 8 others

CompletedA Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic MedicationsThis phase 2, double blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese adults with…NCT03818256·Bentonville, Arkansas and 26 others

CompletedHomeless Youth Study - Stepping Stone 2.0Housing instability is both a cause and consequence of mental health problems.NCT03776422·Chicago, Illinois

CompletedStudy to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831This study will evaluate the long-term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar…NCT03201757·Little Rock, Arkansas and 84 others

CompletedComparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase SchizophrenicsThe goal of this project is to show that the best possible option for preventing relapses in patients suffering from first episode (\<1 year of anti-psychotic medication) or early…NCT02360319·Tucson, Arizona and 38 others

CompletedIntramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaThe purpose of the this trial is to evaluate the efficacy, safety, and tolerability of an intramuscular (IM) depot formulation of aripiprazole as maintenance treatment in patients…NCT00706654·Cerritos, California and 97 others

CompletedThe Management of Schizophrenia in Clinical Practice (MOSAIC)This study is a disease-based registry designed to follow patients with a DSM-IV-TR (Diagnostic and Statistic Manual of Mental Disorders, Text Revision) diagnosis of…NCT01746134·Granada Hills, California and 43 others

CompletedAripiprazole Open-Label, Safety and Tolerability StudyThe purpose of this study is to test the long-term safety and tolerability of aripiprazole in adolescent patients with schizophrenia, and child and adolescent patients with…NCT00102518·Birmingham, Alabama and 49 others

CompletedVirtual Reality Job Interview Training in Severe Mental IllnessThis is a randomized controlled trial to evaluate the community-based effectiveness of virtual reality job interview training (VR-JIT).NCT03049813·Chicago, Illinois and 3 others

CompletedA Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)This study will evaluate the efficacy of ALKS 3831 in adult subjects with acute exacerbation of schizophrenia.NCT02634346·Little Rock, Arkansas and 30 others

RecruitingNBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With SchizophreniaThis study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.NCT07114874·Bryant, Arkansas and 60 others

CompletedAn Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaThis study will evaluate the safety, tolerability, and pharmacokinetics (PK) of various doses and dosing intervals of aripiprazole lauroxil.NCT02320032·Little Rock, Arkansas and 15 others

CompletedEfficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive DeficitsThe primary objective of this study is to evaluate if adjunctive armodafinil treatment can improve the cognitive deficits in patients with schizophreniaNCT00487942·Garden Grove, California and 11 others

CompletedA Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.The objective of the study is to investigate the efficacy, safety and tolerability of four different doses of BI 409306 once daily compared to placebo given for 12 weeks in…NCT02281773·Little Rock, Arkansas and 42 others

CompletedStudy to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I DisorderThis study will evaluate the effect of ALKS 3831 compared to olanzapine on body weight in young adults with schizophrenia, schizophreniform, or bipolar I disorder who are early in…NCT03187769·Little Rock, Arkansas and 56 others

CompletedA Study of Paliperidone Palmitate 6-Month FormulationThe purpose of this study is to demonstrate that injection cycles consisting of a single administration of paliperidone palmitate 6-month (PP6M) are not less effective than 2…NCT03345342·Rogers, Arkansas and 137 others

RecruitingBiomarkers/Biotypes, Course of Early Psychosis and Specialty ServicesThe Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia…NCT06740383·Hartford, Connecticut and 5 others

PreviousPage 3 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia